Two Sigma Securities, LLC Leap Therapeutics, Inc. Transaction History

Two Sigma Securities, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.42 - $9.18 $5,715 - $124,930	13,609 New	13,609 $6,000
Q2 2022 Aug 15, 2022	BUY	$0.96 - $1.91 $16,770 - $33,365	17,469 New	17,469 $20,000
Q4 2021 Feb 14, 2022	SELL	$2.08 - $3.65 $99,384 - $174,400	-47,781 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.35 - $4.01 $26,266 - $78,022	19,457 Added 68.69%	47,781 $192,000
Q2 2021 Aug 16, 2021	BUY	$1.48 - $1.92 $41,919 - $54,382	28,324 New	28,324 $46,000
Q4 2019 Feb 14, 2020	SELL	$0.63 - $1.37 $6,812 - $14,815	-10,814 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$1.17 - $2.36 $12,652 - $25,521	10,814 New	10,814 $13,000

265K

Ticker LPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,021,400
Market Cap $254M
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.